Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
This is a 60-to-72 week multicenter study to evaluate Infergen and Ribavirin in patients with Chronic Hepatitis C Virus after partial response to treatment using peginterferon-alfa and Ribavirin therapy. The study will be conducted at approximately 50 sites across the United States.
Epistemonikos ID: 60a150f05800ad7bdaf353518b5a5f5878a87930
First added on: Mar 23, 2020